← All organizations

Summit Therapeutics

For profitWebsite ↗

Also known as: SUMMIT BIOSCI | Summit (Oxford) Limited | Summit Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 30, 2026

Timeline

2000s

Jun 1, 2003
Summit Therapeutics— Founded
Mar 30, 2007
DanioLabs— Acquired

2010s

Dec 23, 2017
Discuva— Acquired

Drugs by trial phase (15 distinct, 29 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (33)

NCT07234877CollaboratorPhase 2Apr 30, 2026
NCT07264075CollaboratorPhase 3Jan 31, 2026
NCT07057791CollaboratorPhase 2Dec 31, 2025
NCT07070466CollaboratorPhase 2Dec 12, 2025
NCT07094685CollaboratorPhase 2Nov 18, 2025
NCT07228832Lead sponsorPhase 3Nov 15, 2025
NCT06846346CollaboratorPhase 2Sep 30, 2025
NCT06959550CollaboratorPhase 2Jul 28, 2025
NCT07017673CollaboratorPhase 2Jul 25, 2025
NCT06980077CollaboratorPhase 2Jul 15, 2025
NCT06940518CollaboratorPhase 2Jul 2, 2025
NCT06925724CollaboratorPhase 2Apr 4, 2025
NCT06840834CollaboratorPhase 2Apr 1, 2025
NCT06672575CollaboratorPhase 1/Phase 2Apr 1, 2025
NCT06805617CollaboratorPhase 2Mar 1, 2025

Details

Founded: Abingdon, GB Jun 1, 2003
Last known activity: Apr 30, 2026